Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,496.30
7.00 (0.28%)
Medium VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.14L Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
21.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,836.8+35.9%
52W High₹2,526.9-1.2%
Current Price
₹2,496.30
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,997.04
Upper Circuit₹2,995.56
Reference Price
₹2,496.30
Investment Checklist
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹2777.4
Head and Shoulders on 1D — target ₹2105.6
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 47.18 (BUY) with 82.1% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
82%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
2406.41
EMA50
2349.82
EMA200
2200.01
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows7
Lower Highs3
Lower Lows2
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹2494.00
₹2370.02
₹2307.95
₹2238.01
₹2163.44
Volume Analysis
TrendINCREASING
Change+25.70%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹2471.34
3% Risk₹2421.41
5% Risk₹2371.49
7% Risk (Custom)
₹2321.56Technical Levels
1x ATR (Volatility)₹2445.68
2x ATR (Swing)₹2395.06
3x ATR (Trend)₹2344.44
Immediate Support₹2494.00
Moving Averages
EMA 9 (Short-term)₹2458.25
EMA 20 (Medium-term)₹2406.41
EMA 50 (Trend)₹2349.82
EMA 200 (Long-term)₹2200.01
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹5,618.6 Cr | ₹5,562.2 Cr | ₹6,163.8 Cr | ₹7,100.5 Cr |
| Net Profit | ₹855.2 Cr | ₹772.5 Cr | ₹1,219 Cr | ₹1,175.6 Cr |
| EPS | ₹18.75 | — | ₹26.70 | ₹25.74 |
| Operating Profit | ₹1,409.6 Cr | ₹1,353.8 Cr | ₹1,692.8 Cr | ₹1,950 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Biocon Limited | ₹418.50 | +3.70% | 177.4 | ₹67.83K Cr mid Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 25 Jul 2025 | Dividend - Rs 12 Per Share | DIVIDEND |
| 16 Jul 2024 | Dividend - Rs 8 Per Share | DIVIDEND |
| 14 Jul 2023 | Dividend - Rs 4 Per Share | DIVIDEND |
| 14 Jul 2022 | Dividend - Rs 4 Per Share | DIVIDEND |
| 27 Jul 2021 | Dividend - Rs 6.50 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for LUPIN
View All
positive
NDTV Profit 2d ago
Buy, Sell Or Hold: L&T, Avenue Supermarts, Canara Bank, Uno Minda And Lupin — Ask Profit
Market experts shared buy, sell and hold recommendations for an array of stocks.
BANKINDIACANBKDMARTLUPINMINDACORPUNOMINDAAutomobile and Auto ComponentsConsumer Services
positive
Business Standard - Markets 3d ago
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEACUTAASALIVUSBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYHIKALIOLCPJFLLIFEJFL-REJGCHEMLUPINMOMENTUMNIFTYQLITYORCHPHARMARPGLIFESAILIFESILVERSOLARASPARCSUVENTECHChemicalsFinancial Services
positive
ET Markets - Stocks 4d ago
IndusInd Bank among 6 stocks to hit 52-week highs & rally up to 25% in a month
Six BSE 100 stocks, including Cholamandalam Investment, IndusInd Bank and Lupin, touched fresh 52-week highs as the Sensex climbed 521 points. The milestone reflects strong buying interest, positive momentum and growing investor confidence amid the broader market rally.
AONETMMQ50BANKINDIABFINVESTBSEBSLSENETFGCHOLAFINESENSEXHDFCSENSEXINDUSINDBKLUPINMIDSMALLMOMENTUMNEXT30ADDSBIBPBSENSEXADDSENSEXAXISSENSEXBETASENSEXETFSENSEXIETFSMALLCAPSNXT30BEESSNXT50BETAFinancial ServicesHealthcare